IGM Biosciences (IGMS)
(Delayed Data from NSDQ)
$9.09 USD
-0.15 (-1.62%)
Updated May 29, 2024 04:00 PM ET
After-Market: $9.09 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Brokerage Reports
0 items in cart
IGM Biosciences, Inc. [IGMS]
Reports for Purchase
Showing records 81 - 87 ( 87 total )
Company: IGM Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: IGM Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
AACR II 2020 Abstract Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: IGM Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Q1 Financials; Initial Data for ?2323 Remains on Track for YE:20
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: IGM Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Time to Bring the B (Cell) Team into the COVID Wars
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: IGM Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: IGM Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Initiating at OUTPERFORM and $73 PT; Many Hands Makes Effective Antibodies
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R